Healthcare & Medical
Category / Healthcare & Medical
London: Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement from X4 today that their Marketing Authorization Application (MAA) for mavorixafor for the treatme ...
Klosterneuburg, Austria: New study reveals crucial differences in gene activity and opens up personalized therapeutic approaches
...
: New study at IMC Krems provides basic data on the qualifications of Austrian physiotherapists ...
Andernach: LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company, is proud to announces its selection as a Concept Stage winner for two projects in the #PatchForwardPrize, a $5 ...
HONG KONG: HONG KONG, Jan 9, 2025 - (ACN Newswire) – The trading of TCE (T Cell Engager) bispecific antibodies remains hot, and multinational pharmaceutical companies (MNCs) are still placing orders franticall ...
Waiblingen: The test covers the most important bacterial pathogens across all age groups with a single cartridge
- The Vivalytic test is a PCR rapid test that specifically detects the six most common causes o ...
Aachen, Germany: Grünenthal announced today that Prof. Dr. Uli Brödl will assume the role of Chief Scientific Officer (CSO) and Member of the Corporate Executive Board, effective 01 February 2025.
Uli Brödl has m ...
Heidelberg:
- Growth strategy: medium-term sales potential of more than € 300 million
- Growth drivers in the core business: packaging, digital printing Software and lifecycle business
- Industrial busine ...
SHANGHAI: SHANGHAI, China - January 2, 2025 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK, 'Everest', or the 'Company'), a biopharmaceutical company focused on the discovery, clinical d ...
HONG KONG: Laid solid foundation for modular design in isolation facility construction technology
...
TOKYO: TOKYO, Dec 24, 2024 - (JCN Newswire) - Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, today announced that it has be ...
Shanghai: - Officially Benefiting Mainland China Patients ...
Philippines: - by the National Medical Products Administration of China for the Treatment of Moderately to Severely Active Ulcerative Colitis ...
Klosterneuburg, Austria: Lack of follow-up care for breast implants leads to delayed detection of ruptures. A new study highlights the risk of serious long-term consequences and calls for greater awareness. ...
Düsseldorf:
- Innovative combination product of furosemide and on-body device
- Ready-to-market device designed, developed and manufactured by Gerresheimer
- Patented device technology for precise administr ...
HONG KONG: - Officially Beginning to Benefit Asian Patients
...
Klosterneuburg, Austria: Groundbreaking findings on treatment optimization for large sacral chordomas. Researchers at MedAustron Ion Therapy Center and Karl Landsteiner University of Health Sciences improve methods for energy ...
HONG KONG: HONG KONG, Dec 11, 2024 - (ACN Newswire) – As reported by the South China Morning Post today, Everest Medicines (HKEX 1952.HK) is accelerating its journey to become a leading biopharmaceutical compa ...
Freising: Why is the cultivation of regional foods crucial for reducing carbon dioxide emissions? How can innovative research on apple varieties help combat allergies? Dr. Clemens Röhrl, project leader of the ...
SHANGHAI: - Patients in the low-dose cohort who have completed 36 weeks of treatment, 9 out of 11 (81.8%) achieved overall clinical remission and 10 out of 11 (91%) achieved immunological complete remission.
- ...